Price T Rowe Associates Inc Pacific Biosciences Of California, Inc. Transaction History
Price T Rowe Associates Inc
- $816 Billion
- Q1 2024
A detailed history of Price T Rowe Associates Inc transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 1,955,382 shares of PACB stock, worth $3.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,955,382
Previous 3,599,275
45.67%
Holding current value
$3.5 Million
Previous $35.3 Million
79.23%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding PACB
# of Institutions
293Shares Held
253MCall Options Held
1.42MPut Options Held
1.18M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33.3MShares$59.6 Million0.89% of portfolio
-
Vanguard Group Inc Valley Forge, PA26.6MShares$47.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY23.4MShares$41.9 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA17.6MShares$31.5 Million9.04% of portfolio
-
Nikko Asset Management Americas, Inc.12.8MShares$23 Million0.48% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $402M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...